Ironwood Pharmaceuticals (IRWD) Interest Expenses (2010 - 2026)
Ironwood Pharmaceuticals (IRWD) posted Interest Expenses of $9.1 million for Q1 2026, up 142.18% sequentially from -$21.7 million in Q4 2025, and up 13.27% YoY from $8.1 million in Q1 2025.
Ironwood Pharmaceuticals (IRWD) Interest Expenses (2010 - 2026) Analysis & Trends
Ironwood Pharmaceuticals has reported Interest Expenses for 17 years, with the latest figure at $9.1 million in Q1 2026.
- Quarterly Interest Expenses rose 13.27% year-over-year to $9.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.3 million (down 87.25% YoY) and the FY2025 annual result came in at $126.3 million, up 18.84% from the prior year.
- Interest Expenses advanced to $9.1 million in Q1 2026 per IRWD's latest filing, from -$21.7 million in the prior quarter.
- Over five years, Interest Expenses peaked at $18.3 million in Q4 2023 and troughed at -$21.7 million in Q4 2025.
- A 5-year average of $4.8 million and a median of $7.5 million in 2024 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2023 and 2025: Interest Expenses soared 5682.26% in 2023, then slumped 356.67% in 2025.
- Over 5 years, Interest Expenses stood at -$327000.0 in 2022, then jumped by 5682.26% to $18.3 million in 2023, then sank by 53.75% to $8.4 million in 2024, then plunged by 356.67% to -$21.7 million in 2025, then soared by 142.18% to $9.1 million in 2026.
- According to Business Quant data, Interest Expenses over the past three periods registered $9.1 million, -$21.7 million, and $8.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Ironwood Pharmaceuticals | 688.86 Mn | 609.73 Mn | - | 7.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.24 Mn |
| Jun 30, 2026 | 13.24 Mn |
| Mar 31, 2026 | 9.14 Mn |
| Mar 31, 2026 | 9.14 Mn |
| Dec 31, 2025 | -21.67 Mn |
| Dec 31, 2025 | -21.67 Mn |
| Sep 30, 2025 | 8.43 Mn |
| Sep 30, 2025 | 8.43 Mn |
| Jun 30, 2025 | 8.36 Mn |
| Jun 30, 2025 | 8.36 Mn |
| Mar 31, 2025 | 8.07 Mn |
| Mar 31, 2025 | 8.07 Mn |
| Dec 31, 2024 | 8.44 Mn |
| Dec 31, 2024 | 8.44 Mn |
| Sep 30, 2024 | 9.42 Mn |
| Sep 30, 2024 | 9.42 Mn |
| Jun 30, 2024 | 7.47 Mn |
| Jun 30, 2024 | 7.47 Mn |
| Mar 31, 2024 | 7.23 Mn |
| Mar 31, 2024 | 7.23 Mn |